Cramer Says 'I Can't Tell You To Sell It Here,' As Massive Pharma Stock Falls 34% YTD
Portfolio Pulse from Priya Nigam
Jim Cramer, on CNBC's 'Mad Money Lightning Round', gave his views on several stocks. He mentioned that Paycom Software (PAYC) is going out of fashion, Dollar General (DG) did not deliver great numbers, Iridium Communications (IRDM) is doing well, Tilray Brands (TLRY) is too dangerous, Fastly (FSLY) has not pivoted to profitability, and Pfizer (PFE) is a good company and he wouldn't recommend selling it.
September 19, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jim Cramer said Dollar General did not deliver great numbers.
Jim Cramer's comments can influence investor sentiment. His negative comments about Dollar General's performance could lead to a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jim Cramer said Fastly has not pivoted to profitability.
Jim Cramer's comments can influence investor sentiment. His negative comments about Fastly's profitability could lead to a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jim Cramer mentioned that Paycom Software is going out of fashion.
Jim Cramer's comments can influence investor sentiment. His statement that Paycom Software is going out of fashion could lead to a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jim Cramer said Tilray Brands is too dangerous.
Jim Cramer's comments can influence investor sentiment. His negative comments about Tilray Brands could lead to a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jim Cramer said Iridium Communications is doing well.
Jim Cramer's comments can influence investor sentiment. His positive comments about Iridium Communications could lead to a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jim Cramer said Pfizer is a good company and he wouldn't recommend selling it.
Jim Cramer's comments can influence investor sentiment. His positive comments about Pfizer could lead to a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100